Acumen Pharmaceuticals, Inc. (ABOS)
3.18
+0.09
(+2.91%)
USD |
NASDAQ |
Sep 04, 16:00
3.17
-0.01
(-0.31%)
After-Hours: 20:00
Acumen Pharmaceuticals Total Assets (Quarterly) : 116.01M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 116.01M |
| March 31, 2026 | 133.63M |
| December 31, 2025 | 123.00M |
| September 30, 2025 | 142.22M |
| June 30, 2025 | 171.90M |
| March 31, 2025 | 204.48M |
| December 31, 2024 | 238.99M |
| September 30, 2024 | 266.98M |
| June 30, 2024 | 288.91M |
| March 31, 2024 | 300.97M |
| December 31, 2023 | 310.12M |
| September 30, 2023 | 286.37M |
| Date | Value |
|---|---|
| June 30, 2023 | 177.40M |
| March 31, 2023 | 187.86M |
| December 31, 2022 | 196.59M |
| September 30, 2022 | 203.26M |
| June 30, 2022 | 211.68M |
| March 31, 2022 | 220.09M |
| December 31, 2021 | 230.33M |
| September 30, 2021 | 234.85M |
| June 30, 2021 | 72.94M |
| March 31, 2021 | 42.37M |
| December 31, 2020 | 44.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 32.09B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.74M |
| Shareholders Equity (Quarterly) | 57.26M |
| Debt to Equity Ratio | 0.5526 |
| Current Ratio | 2.466 |
| Net Debt Paydown Yield | -0.19% |